what is savella for
Savella (milnacipran HCl) is a selective norepinephrine and serotonin reuptake inhibitor (SNRI) used to treat a chronic pain disorder called fibromyalgia.
Updated April 10, 2016. On January 14, 2009, the FDA approved Savella (milnacipran HCl) for the management of fibromyalgia. Savella is classified as a selective serotonin and norepinephrine dual reuptake inhibitor. The drug has been used for several years in Europe and Asia to treat depression.